A new over-the-counter option for red eyes has been approved. On October 16, 2026, the FDA approved Brytly (apraclonidine ophthalmic solution 0.125%, made by Alcon) as a nonprescription eye drop for relief of eye redness caused by minor irritations. It ...
iMedix: Independent Drug & Health Platform Latest Articles
FDA Approves Remibrutinib (Rhapsido) as First Treatment for Symptomatic Dermographism
People whose skin breaks out in itchy welts from simple rubbing or scratching now have a medicine approved for that specific problem. The FDA has approved remibrutinib (Rhapsido), an oral drug, for adults with symptomatic dermographism whose symptoms are not ...
FDA Approves Tecentriq With Chemotherapy After Surgery for Stage III dMMR Colon Cancer
People with stage III colon cancer whose tumors are mismatch repair-deficient (dMMR) now have an immunotherapy option after surgery. The FDA has approved atezolizumab (Tecentriq), and its under-the-skin formulation Tecentriq Hybreza, in combination with a fluoropyrimidine and oxaliplatin as adjuvant ...
U.S. Measles Cases Pass 4,000 as New York Declares a Statewide Emergency
The United States has now recorded more than 4,000 confirmed measles cases this year. As of October 8, 2026, the CDC counted 4,080 cases reported by 47 jurisdictions, up from 3,887 a week earlier and already 78% above the 2,289 ...
Kenya Confirms First Case as Bundibugyo Ebola Outbreak Becomes the Second-Largest on Record
Kenya has confirmed its first case of Ebola disease caused by Bundibugyo virus, the strain behind the outbreak declared in the Democratic Republic of the Congo (DRC) in May. The government notified the World Health Organization on October 6, 2026, ...
FDA Approves Tukysa as a Chemotherapy-Free Maintenance Option for HER2-Positive Metastatic Breast Cancer
Tucatinib (Tukysa), an oral HER2-targeted drug, can now be used earlier in the treatment of advanced HER2-positive breast cancer. The FDA has approved it, together with the antibodies trastuzumab and pertuzumab, as maintenance therapy for adults whose cancer is unresectable ...
FDA Approves Tavapadon (Juvmo), a Dopamine Agonist With a New Target for Parkinson’s Disease
The FDA has approved tavapadon, sold as Juvmo, a once-daily tablet for adults with Parkinson’s disease. The agency’s list of novel drug approvals dates the decision to September 25, 2026 (FDA); manufacturer AbbVie announced it three days later (AbbVie). What ...
Florida Dengue Outbreak Tops 250 Local Cases, With Tampa Bay at the Center
Florida’s outbreak of locally acquired dengue has not slowed. The state’s weekly surveillance report for September 20–26 counts 252 cases this year in people who caught the virus from mosquitoes inside Florida, up from 152 just two reports earlier. Close ...
Gum Disease Bacteria May Be Hardening Heart Valves, Early Research Suggests.
The bacteria behind gum disease may not stop at your teeth. New preliminary research suggests they can reach the heart’s aortic valve, driving the inflammation and calcium buildup behind one of the most common — and most serious — heart ...